Research
Behind the Scenes: How We Are Shaping the Future of PSC Research
We have been busy behind the scenes, co-authoring vital research to turn scientific discovery into real-world tools.
Read MoreVISTAS Phase 2b Trial Results May 2026
New trial data shows volixibat significantly reduces severe itch for people with PSC.
Read MoreApril 2026 Research Roundup
Discover how PSC Support is accelerating research, from novel diagnostics to gut health, this month.
Read MoreSABR-PSC Clinical Trial Results
Early-phase study shows brodalumab is safe and well-tolerated in people with PSC.
Read MoreMarch 2026 Research Roundup
A summary of recent clinical trial results, new research funding, and a historic NICE evaluation.
Read MoreRitivixibat (A3907) Phase 2 Clinical Trial Results
Safety results for the Phase 2 ritivixibat study (A3907) for PSC have been released.
Read MorePiSCATIN study reaches full recruitment milestone
The PiSCATIN study has enrolled 570 participants, moving us closer to potential PSC treatments.
Read MorePSC Support Signs Landmark European Declaration to Accelerate Rare Disease Innovation
PSC Support joins European leaders to advocate for a cohesive ecosystem in rare disease care.
Read MoreFebruary 2026 Research Roundup
A month of leadership growth, breakthrough research, and new milestones in clinical care.
Read MoreDriving Global Change Through the Patient Voice
New global survey results reveal the significant impact of itch on life with PSC.
Read More